Experience with botulinum toxin in chronic migraine.

OBJECTIVE The purposes of this study were to describe our 16-month experience with onabotulinumtoxinA (OnabotA) for the treatment of chronic migraine (CM) in the Spanish province of Segovia, evaluate its benefits, and determine clinical markers of good response to treatment. PATIENTS AND METHODS Prospective study of patients with CM who received OnabotA… CONTINUE READING